Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Forte Biosciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −9 vs. Q2 2024
- Shares held
- 736.6K
- −19.1K (−2.5%) vs. Q2 2024Converted for a 1-for-25 split
- Total value
- $4.12M
- −$6.03M (−59.4%) vs. Q2 2024
- New holders
- 3
- 7 more added
- Sold out
- 12
- 8 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tybourne Capital Management (HK) Ltd | 144,981 | $810.4K | 0.23% | 00.0% | UnchangedConverted for a 1-for-25 split |
| BVF Inc | 119,282 | $668.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Perceptive Advisors LLC | 95,742 | $535.2K | 0.01% | −34,872−26.7% | ReducedConverted for a 1-for-25 split |
| Fred Alger Management, LLC | 82,698 | $462.3K | 0.00% | +9,139+12.4% | AddedConverted for a 1-for-25 split |
| Cable Car Capital LLC | 81,279 | $454.4K | 0.49% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Farallon Capital Management, L.L.C. | 72,413 | $405.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| BML Capital Management, LLC | 70,468 | $393.9K | 0.23% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Vanguard Group Inc | 26,394 | $147.8K | 0.00% | −215−0.8% | ReducedConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 14,270 | $79.9K | 0.00% | +418+3.0% | AddedConverted for a 1-for-25 split |
| Susquehanna International Group, LLP | 13,096 | $73.3K | 0.00% | +11,722+853.3% | AddedConverted for a 1-for-25 split |
| BlackRock, Inc. | 6,803 | $38.0K | 0.00% | +6,803 | New |
| ADAR1 Capital Management, LLC | 6,000 | $33.5K | 0.01% | −370−5.8% | ReducedConverted for a 1-for-25 split |
| UBS Group AG | 1,606 | $8.98K | 0.00% | +634+65.2% | AddedConverted for a 1-for-25 split |
| Tower Research Capital LLC (TRC) | 806 | $4.51K | 0.00% | +174+27.5% | AddedConverted for a 1-for-25 split |
| Group One Trading, L.P. | 559 | $3.13K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Morgan Stanley | 151 | $844 | 0.00% | −1−0.8% | ReducedConverted for a 1-for-25 split |
| Bank of America Corp | 23 | $129 | 0.00% | +12+117.0% | AddedConverted for a 1-for-25 split |
| Advisor Group Holdings, Inc. | 20 | $112 | 0.00% | −23−53.7% | ReducedConverted for a 1-for-25 split |
| Russell Investments Group, Ltd. | 18 | $100 | 0.00% | −0−0.7% | ReducedConverted for a 1-for-25 split |
| BNP Paribas Arbitrage, SA | 8 | $45 | 0.00% | +8 | New |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 7 | $32 | 0.00% | −1−9.3% | ReducedConverted for a 1-for-25 split |
| REAP Financial Group, LLC | 3 | $17 | 0.00% | −1−22.7% | ReducedConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 3 | $17 | 0.00% | +2+341.2% | AddedConverted for a 1-for-25 split |
| Barclays PLC | 1 | $6 | 0.00% | +1 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −5,336−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −1,632−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −1,503−100.0% | Sold outConverted for a 1-for-25 split |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −881−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,073−100.0% | Sold outConverted for a 1-for-25 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −831−100.0% | Sold outConverted for a 1-for-25 split |
| Aries Wealth Management | 0 | $0 | 0.00% | −520−100.0% | Sold outConverted for a 1-for-25 split |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −430−100.0% | Sold outConverted for a 1-for-25 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −324−100.0% | Sold outConverted for a 1-for-25 split |
| FMR LLC | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-25 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-25 split |
| BlackRock Inc. | – | – | – | – | Not filed |